修正:对于孕期糖尿病女性药理治疗的多变量预测模型:算法开发和验证
Carmelo Velardo1,2, David Clifton1,2, Steven Hamblin1
1Sensyne Health, plc, Oxford, United Kingdom.
Journal of medical Internet research
|October 15, 2025
概括
这项研究纠正了先前发表的一篇文章DOI. 校正确保了准确的引用,以确保未来的科学研究和数据完整性.
科学领域:
- 科学出版业的科学出版.
- 图书统计学 图书统计学
- 学术传播学术交流
背景情况:
- 准确的引用对于科学完整性至关重要.
- 数字物体识别器 (DOI) 对于定位学术文章至关重要.
- 校正通知是学术出版的标准部分.
研究的目的:
- 纠正以前发表的文章的数字物体标识符 (DOI).
- 为了确保研究人员准确地检索文章.
- 维护科学记录的完整性.
主要方法:
- 发出了一份正式的纠正通知.
- 错误的DOI被识别并标记.
- 对该物品提供了正确的DOI.
主要成果:
- 文章DOI已经被纠正.
- 读者现在可以使用准确的DOI访问文章.
- 这确保了正确的归因和引用.
结论:
- 校正保持了科学文献的可靠性.
- 准确的DOI有助于有效的学术交流.
- 这确保了科学记录的准确性和可靠性.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes: Management and Pharmacotherapy
867
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
867
Analysis of Population Pharmacokinetic Data
677
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
677
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Pharmacokinetic Models: Comparison and Selection Criterion
334
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
334


